Source: Jason Parker, WRAL TECHWIRE, 11/2/21

 EmitBio™, a Durham-based biotechnology company operating as a subsidiary of KNOW Bio, has been issued a new U.S. patent that protects the company’s novel COVID-19 treatment: light. “In my opinion, we have the best treatment option versus any other available today, said Neal Hunter, CEO of KNOW Bio and Executive Chairman of the Board of Directors at EmitBio Inc.  “This is supported by over 10,000 invitro experiments and multiple human trials including safety and efficacy.”

For more of this story, click here.